10 employees
Vitruvias Therapeutics focuses on developing niche topical generic products that are sold only by prescription.
2013
$12M
from 2 investors over 2 rounds
Vitruvias Therapeutics, Inc. raised $12M on January 5, 2018
Investors: JW ASSET MANAGEMENT, LLC and Perceptive Advisors